Topic108 documents tagged
Finance Signal
Pharmaceuticals
What This Page Covers
This page collects the 108 public records POLISCOPE has tagged with “Pharmaceuticals”. Coverage spans bills, news coverage, and campaign-finance records - each decoded into plain English and linked to its primary source. It most often overlaps with Healthcare, Fda, and Public Health.
Active Bills
California SB 1185 requires pharmaceutical facility construction projects to use a 'skilled and trained' workforceOwners and developers of pharmaceutical research and production facilities must now ensure all onsite construction, maintenance, and repair work is performed by a 'skilled and trained' workforce. ContProposed Changes to Biosimilar Drug Review ProcessSECURE 340B Act
Recent Activity
- Mon, Aug 311 item
- Thu, Aug 271 item
- Wed, Aug 262 items
- Vitruvias Therapeutics recalls specific lot of 30 mg thyroid tablets due to superpotency riskVitruvias Therapeutics has issued a voluntary recall for one lot of its 30 mg Thyroid Tablets, USP, because the medication may be 'superpotent,' potentially causing hyperthyroidism. The recall affects
- FDA approves new pancreatic cancer treatment
- Mon, Aug 241 item
- Wed, Aug 193 items
- Moderna and Merck report successful late-stage trial for personalized mRNA melanoma vaccineModerna announced that its personalized mRNA cancer vaccine, when used alongside the immunotherapy drug Keytruda, reduced the risk of melanoma recurrence or spread in a late-stage clinical trial. The
- Moderna and Merck report positive initial results for experimental mRNA cancer vaccine
- Merck and Moderna report experimental mRNA melanoma vaccine reduces cancer recurrence in late-stage trial
Finance Signals
Finance-tagged records
4records associated with this topic
LobbyingCALACCESS COUNTYJun 20, 2026
Lobbying Disclosure: California Society of Health-System Pharmacists (Q2 2000)
LobbyingCALACCESS COUNTYJun 20, 2026
Lobbying Disclosure: Cardinal Health Inc. (Q1 2000)
LobbyingCALACCESS COUNTYJun 20, 2026
Lobbying Disclosure: Pharmaceutical Research and Manufacturers of America (Q1 2000)
LobbyingCALACCESS COUNTYJun 20, 2026
Lobbying Disclosure: Pfizer Inc. (Q1 2000)
Reported financial relationships and timing signals. This does not prove motive or influence.
Key Actors
- 01Food and Drug Administrationorganization5 mentions
- 02Donald Trumpperson3 mentions
- 03Vitruvias Therapeutics, Inc.organization3 mentions
- 04Merckorganization3 mentions
- 05504950other3 mentions
- 06Modernaorganization2 mentions
- 07Amy Klobucharperson2 mentions
- 08Stephane Bancelperson2 mentions
- 0911other2 mentions
- 10Department of Defenseorganization2 mentions
Connections Preview
Lightweight relationship summary. Open the full graph for the interactive view, including 1-hop neighbours and money edges.
- Topic to billsCalifornia SB 1185 requires pharmaceutical facility construction projects to use a 'skilled and trained' workforce, Proposed Changes to Biosimilar Drug Review Process, SECURE 340B Act
- Topic to peopleDonald Trump, Amy Klobuchar, Stephane Bancel
- Topic to orgsFood and Drug Administration, Vitruvias Therapeutics, Inc., Merck (+2 more)
- Topic to financeLobbying Disclosure: California Society of Health-System Pharmacists (Q2 2000), Lobbying Disclosure: Cardinal Health Inc. (Q1 2000), Lobbying Disclosure: Pharmaceutical Research and Manufacturers of America (Q1 2000) (+1 more)
Source Trail
Documents whose extracted record lists this topic. Each item opens the Bill Dossier, which includes the official source URL when available.
- Aug 31, 2026NewsFlorida Attorney General investigates Pharmacy Benefit Managers for alleged monopolistic practices
- Aug 27, 2026NewsOpinion piece argues for the role of patents in pharmaceutical innovation
- Aug 26, 2026NewsFDA approves new pancreatic cancer treatment
- Aug 26, 2026NewsVitruvias Therapeutics recalls specific lot of 30 mg thyroid tablets due to superpotency risk
- Aug 26, 2026NewsVitruvias Therapeutics recalls specific lot of 30 mg thyroid tablets due to superpotency risk
- Aug 26, 2026NewsVitruvias Therapeutics recalls specific lot of 30 mg thyroid tablets due to superpotency risk
- Aug 24, 2026NewsEmerging research suggests GLP-1 medications may assist in addiction treatment
- Aug 19, 2026NewsModerna and Merck report successful late-stage trial for personalized mRNA melanoma vaccine
- Aug 19, 2026NewsModerna and Merck report successful late-stage trial for personalized mRNA melanoma vaccine
- Aug 19, 2026NewsModerna and Merck report positive initial results for experimental mRNA cancer vaccine
Showing 10 of 108 source records.